Skip to main content
SpringerLink
Log in

Bewegung in der Therapie des Typ-2-Diabetes

Bericht vom Diabetes Update 2008

Exercise in the therapy of type 2 diabetes

Report from Diabetes Update 2008

  • Diabetologie aktuell
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. The Look AHEAD Research Group (2008) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care 30: 1374–1383

    Google Scholar 

  2. Sigal RJ, Kenny GP, Boule N et al. (2007) Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147: 357–369

    PubMed  Google Scholar 

  3. Kim D, MacConell L, Zhuang D et al. (2007) Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care 30: 1487–1493

    Article  PubMed  CAS  Google Scholar 

  4. Vilsboll T, Zdravkovic M, Le-Thi T et al. (2007) Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes. Diabetes Care 30: 1608–1610

    Article  PubMed  Google Scholar 

  5. Davis SN, Johns D, Maggs D et al. (2007) Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents. Diabetes Care 30: 2767–2772

    Article  PubMed  CAS  Google Scholar 

  6. Gerstein HC, Riddle MC, Kendall DM et al. (2007) Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 99 (12A): 34i–43i

    Article  PubMed  Google Scholar 

  7. Gaede P, Lund-Andersen H, Parving HH et al. (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580–591

    Article  PubMed  CAS  Google Scholar 

  8. Kempf K, Rose B, Herder C et al. (2007) The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med 85: 389–396

    Article  PubMed  CAS  Google Scholar 

  9. Larsen CM, Faulenbach M, Vaag A et al. (2007) lnterleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356: 1517–1526

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Bergische Landstraße 48, 51503, Rösrath, Deutschland

    L. Riem

Authors
  1. L. Riem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Riem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riem, L. Bewegung in der Therapie des Typ-2-Diabetes. Diabetologe 4, 368–371 (2008). https://doi.org/10.1007/s11428-008-0286-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-008-0286-8

Search

Navigation